Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

2.2 Continous dopaminergic stimulation: concept and evidence

Leo Verhagen Metman  1 , M. Maral Mouradian  2
Per Odin  1   2 , K Ray Chaudhuri  3   2 , Sten-Magnus Aquilonious  2 , Ulrika Mundt-Petersen  2
, editors.
In: Where are We? Continuous Dopaminergic Stimulation for Parkinson's Disease [Internet]. Berkshire (UK): Empowering Strategic Performance Ltd; 2023 Jan 1.
Affiliations
Free Books & Documents
Review

2.2 Continous dopaminergic stimulation: concept and evidence

Leo Verhagen Metman et al.
Free Books & Documents
No abstract available

PubMed Disclaimer

References

    1. Ehringer H, Hornykiewicz O. [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system] Klin Wochenschr. 1960;38:1236–1239. - PubMed
    1. Kordower JH, Olanow CW, Dodiya HB, et al. Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. Brain. 2013;136:2419–2431. - PMC - PubMed
    1. Cotzias GC, Papavasiliou PS, Gellene R. Modification of Parkinsonism–chronic treatment with L-dopa. N Engl J Med. 1969;280:337–345. - PubMed
    1. Barbeau A, Gillo-Joffroy L, Mars H. Treatment of Parkinson's disease with levodopa and Ro 4-4602. Clin Pharmacol Ther. 1971;12:353–359. - PubMed
    1. Ahlskog JE, Muenter MD. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord. 2001;16:448–458. - PubMed

LinkOut - more resources